Zenith Drugs

Zenith Drugs Diluted EPS

The Diluted Earnings per Share of Zenith Drugs (ZENITHDRUG.NS) as of Oct 28, 2026 is 4.18 INR. In the previous year, Diluted Earnings per Share was 5.56 INR — a change of -24.92% (lower).

Diluted EPS

4.18INR

YoY

-24.92%

Last updated:

Diluted Earnings per Share of Zenith Drugs is 2025 4.18 INR. Diluted Earnings per Share of Zenith Drugs was 2024 5.56 INR. It decreases by -24.92% lower compared to the previous year.

The Zenith Drugs Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2023
2.85 INR
Jan 1, 2024
5.56 INR
Jan 1, 2025
4.18 INR
The Zenith Drugs Diluted EPS history
YEARDiluted EPSYoY
4.18INR-24.92%
5.56INR+95.39%
2.85INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Zenith Drugs Stock analysis

What does Zenith Drugs do? Zenith Drugs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenith Drugs stock

Diluted Earnings per Share of Zenith Drugs is 4.18 INR in 2025.

Diluted Earnings per Share of Zenith Drugs changed from 5.56 INR to 4.18 INR, representing a -24.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Zenith Drugs since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Zenith Drugs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Zenith Drugs